Use of mutant 125I-Perfringolysin O to probe transport and organization of cholesterol in membranes of animal cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 26, 2013, Pages 10580-10585

  Das, Akash ^a   Goldstein, Joseph L ^a   Anderson, Donald D ^a   Brown, Michael S ^a   Radhakrishnan, Arun ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CHOLESTEROL; CHOLESTEROL ESTER; CLOSTRIDIUM PERFRINGENS TOXIN; IODINE 125; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; UNCLASSIFIED DRUG; BACTERIAL TOXIN; CLOSTRIDIUM PERFRINGENS THETA TOXIN; CLOSTRIDIUM PERFRINGENS THETA-TOXIN; DIAGNOSTIC AGENT; HEMOLYSIN; MUTANT PROTEIN; RADIOACTIVE IODINE; RECOMBINANT PROTEIN;

ARTICLE; CELL MEMBRANE; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; LIPID HYDROLYSIS; LYSOSOME; PRIORITY JOURNAL; ACTIVE TRANSPORT; AMINO ACID SUBSTITUTION; ANIMAL; CELL LINE; GENETICS; METABOLISM; MOLECULAR PROBE; SITE DIRECTED MUTAGENESIS;

ANIMALIA;

AMINO ACID SUBSTITUTION; ANIMALS; BACTERIAL TOXINS; BIOLOGICAL TRANSPORT, ACTIVE; CELL LINE; CELL MEMBRANE; CHOLESTEROL; HEMOLYSIN PROTEINS; HUMANS; IODINE RADIOISOTOPES; MOLECULAR PROBES; MUTAGENESIS, SITE-DIRECTED; MUTANT PROTEINS; RECOMBINANT PROTEINS;

EID: 84879533612     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1309273110     Document Type: Article

References (32)

1. De Duve C (1971) Tissue fractionation. Past and present. J Cell Biol 50(1):20d-55d.
2. Lange Y, Swaisgood MH, Ramos BV, Steck TL (1989) Plasma membranes contain half the phospholipid and 90% of the cholesterol and sphingomyelin in cultured human fibroblasts. J Biol Chem 264(7):3786-3793.
3. Brown MS, Goldstein JL (1986) A receptor-mediated pathway for cholesterol homeostasis. Science 232(4746):34-47.
4. Lange Y, Ye J, Steck TL (1998) Circulation of cholesterol between lysosomes and the plasma membrane. J Biol Chem 273(30):18915-18922.
5. Liscum L, Munn NJ (1999) Intracellular cholesterol transport. Biochim Biophys Acta 1438(1):19-37.
6. Lange Y (1992) Tracking cell cholesterol with cholesterol oxidase. J Lipid Res 33(3): 315-321.
7. Underwood KW, Jacobs NL, Howley A, Liscum L (1998) Evidence for a cholesterol transport pathway from lysosomes to endoplasmic reticulum that is independent of the plasma membrane. J Biol Chem 273(7):4266-4274.
8. Gimpl G, Gehrig-Burger K (2011) Probes for studying cholesterol binding and cell biology. Steroids 76(3):216-231.
9. Ohno-Iwashita Y, et al. (2010) Cholesterol-binding toxins and anti-cholesterol antibodies as structural probes for cholesterol localization. Subcell Biochem 51:597-621.
10. Flanagan JJ, Tweten RK, Johnson AE, Heuck AP (2009) Cholesterol exposure at the membrane surface is necessary and sufficient to trigger perfringolysin O binding. Biochemistry 48(18):3977-3987.
11. Sokolov A, Radhakrishnan A (2010) Accessibility of cholesterol in endoplasmic reticulum membranes and activation of SREBP-2 switch abruptly at a common cholesterol threshold. J Biol Chem 285(38):29480-29490.
12. Radhakrishnan A, Goldstein JL, McDonald JG, Brown MS (2008) Switch-like control of SREBP-2 transport triggered by small changes in ER cholesterol: A delicate balance. Cell Metab 8(6):512-521.
13. Brown MS, Goldstein JL (1997) The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89(3): 331-340.
14. Yang T, et al. (2002) Crucial step in cholesterol homeostasis: Sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER. Cell 110(4):489-500.
15. Brown AJ, Sun L, Feramisco JD, Brown MS, Goldstein JL (2002) Cholesterol addition to ER membranes alters conformation of SCAP, the SREBP escort protein that regulates cholesterol metabolism. Mol Cell 10(2):237-245.
16. Shimada Y, Maruya M, Iwashita S, Ohno-Iwashita Y (2002) The C-terminal domain of perfringolysin O is an essential cholesterol-binding unit targeting to cholesterol-rich microdomains. Eur J Biochem 269(24):6195-6203.
17. Ishitsuka R, Saito T, Osada H, Ohno-Iwashita Y, Kobayashi T (2011) Fluorescence image screening for chemical compounds modifying cholesterol metabolism and distribution. J Lipid Res 52(11):2084-2094.
18. Hotze EM, et al. (2002) Monomer-monomer interactions drive the prepore to pore conversion of a β-barrel-forming cholesterol-dependent cytolysin. J Biol Chem 277 (13):11597-11605.
19. Nelson LD, Johnson AE, London E (2008) How interaction of perfringolysin O with membranes is controlled by sterol structure, lipid structure, and physiological low pH: Insights into the origin of perfringolysin O-lipid raft interaction. J Biol Chem 283(8): 4632-4642.
20. Kilsdonk EPC, et al. (1995) Cellular cholesterol efflux mediated by cyclodextrins. J Biol Chem 270(29):17250-17256.
21. Goldstein JL, Brown MS (1990) Regulation of the mevalonate pathway. Nature 343 (6257):425-430.
22. Goldstein JL, Brunschede GY, Brown MS (1975) Inhibition of proteolytic degradation of low density lipoprotein in human fibroblasts by chloroquine, concanavalin A, and Triton WR 1339. J Biol Chem 250(19):7854-7862.
23. Underwood KW, Andemariam B, McWilliams GL, Liscum L (1996) Quantitative analysis of hydrophobic amine inhibition of intracellular cholesterol transport. J Lipid Res 37(7):1556-1568.
24. Brown MS, Sobhani MK, Brunschede GY, Goldstein JL (1976) Restoration of a regulatory response to low density lipoprotein in acid lipase-deficient human fibroblasts. J Biol Chem 251(11):3277-3286.
25. Pentchev PG, et al. (1985) A defect in cholesterol esterification in Niemann-Pick disease (type C) patients. Proc Natl Acad Sci USA 82(23):8247-8251.
26. Liscum L, Ruggiero RM, Faust JR (1989) The intracellular transport of low density lipoprotein- derived cholesterol is defective in Niemann-Pick type C fibroblasts. J Cell Biol 108(5):1625-1636.
27. Wattenberg BW, Silbert DF (1983) Sterol partitioning among intracellular membranes. Testing a model for cellular sterol distribution. J Biol Chem 258(4):2284-2289.
28. Goldstein JL, Basu SK, Brown MS (1983) Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol 98:241-260.
29. Brown MS, Faust JR, Goldstein JL, Kaneko I, Endo A (1978) Induction of 3-hydroxy-3- methylglutaryl coenzyme A reductase activity in human fibroblasts incubated with compactin (ML-236B), a competitive inhibitor of the reductase. J Biol Chem 253(4): 1121-1128.
30. Yamamoto T, et al. (1984) The human LDL receptor: A cysteine-rich protein with multiple Alu sequences in its mRNA. Cell 39(1):27-38.
31. Goldstein JL, Brown MS (1979) The LDL receptor locus and the genetics of familial hypercholesterolemia. Annu Rev Genet 13:259-289.
32. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193(1):265-275.